Joint Chiefs of Staff chair Adm. Mike Mullen (center) with US troops in Haiti, 2010 (photo: Chad J. McNeeley/DoD)

This week on CounterSpin: There are enough storylines in the July 7 assassination of Haitian president Jovenel Moïse to make you lose sight of the big picture. The thing is: US media consumers don’t have to puzzle out if the assassins were Colombian, or if a Florida doctor bankrolled the plan, or if Moïse’s own bodyguards had it in for him and his wife. The long history of the US using state force to kill Haitians and their aspirations is sufficient and appropriate context for current events. From George Washington to Woodrow Wilson to the Clintons, there’s enough for US citizens to know about not doing harm before we chinstroke over whether “the world’s policeman” should wade in again. We talk about Haiti with Chris Bernadel from the Black Alliance for Peace.

Also on the show: Cronyism between pharmaceutical companies and their ostensible government regulators is an infuriating fact of US life, along with the unsurprisingly obscene cost of drugs. Yet somehow the story of aducanumab takes it to a new level. We talk about what pharma and the FDA call a breakthrough Alzheimer’s drug, and what public advocates call an example of all that’s wrong with the FDA, with Michael Carome, M.D., director of the Health Research Group at Public Citizen.

The post Chris Bernadel on Haitian Assassination, Michael Carome on FDA Alzheimer’s Investigation appeared first on FAIR.

This post was originally published on FAIR.